423 related articles for article (PubMed ID: 26342897)
21. Microglial LRRK2-mediated NFATc1 attenuates α-synuclein immunotoxicity in association with CX3CR1-induced migration and the lysosome-initiated degradation.
Feng L; Lo H; Hong Z; Zheng J; Yan Y; Ye Z; Chen X; Pan X
Glia; 2023 Sep; 71(9):2266-2284. PubMed ID: 37300531
[TBL] [Abstract][Full Text] [Related]
22. P2X7 receptor is critical in α-synuclein--mediated microglial NADPH oxidase activation.
Jiang T; Hoekstra J; Heng X; Kang W; Ding J; Liu J; Chen S; Zhang J
Neurobiol Aging; 2015 Jul; 36(7):2304-2318. PubMed ID: 25983062
[TBL] [Abstract][Full Text] [Related]
23. α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes.
Du RH; Zhou Y; Xia ML; Lu M; Ding JH; Hu G
J Neuroinflammation; 2018 Sep; 15(1):258. PubMed ID: 30200997
[TBL] [Abstract][Full Text] [Related]
24. Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease.
Zhang YN; Fan JK; Gu L; Yang HM; Zhan SQ; Zhang H
J Neuroinflammation; 2021 Jan; 18(1):23. PubMed ID: 33461598
[TBL] [Abstract][Full Text] [Related]
25. Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells.
Kim C; Kwon S; Iba M; Spencer B; Rockenstein E; Mante M; Adame A; Shin SJ; Fields JA; Rissman RA; Lee SJ; Masliah E
Exp Mol Med; 2021 Feb; 53(2):281-290. PubMed ID: 33594256
[TBL] [Abstract][Full Text] [Related]
26. Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1.
Li Y; Wang Y; Kou L; Yin S; Chi X; Sun Y; Wu J; Jin Z; Zhou Q; Zou W; Wang T; Xia Y
CNS Neurosci Ther; 2024 May; 30(5):e14738. PubMed ID: 38702933
[TBL] [Abstract][Full Text] [Related]
27. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
[TBL] [Abstract][Full Text] [Related]
28. α-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson's disease.
Tu HY; Yuan BS; Hou XO; Zhang XJ; Pei CS; Ma YT; Yang YP; Fan Y; Qin ZH; Liu CF; Hu LF
Aging Cell; 2021 Dec; 20(12):e13522. PubMed ID: 34811872
[TBL] [Abstract][Full Text] [Related]
29. Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model.
Sommer A; Fadler T; Dorfmeister E; Hoffmann AC; Xiang W; Winner B; Prots I
J Neuroinflammation; 2016 Jun; 13(1):174. PubMed ID: 27364890
[TBL] [Abstract][Full Text] [Related]
30. Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration.
Gao HM; Kotzbauer PT; Uryu K; Leight S; Trojanowski JQ; Lee VM
J Neurosci; 2008 Jul; 28(30):7687-98. PubMed ID: 18650345
[TBL] [Abstract][Full Text] [Related]
31. Identification of proteins involved in microglial endocytosis of alpha-synuclein.
Liu J; Zhou Y; Wang Y; Fong H; Murray TM; Zhang J
J Proteome Res; 2007 Sep; 6(9):3614-27. PubMed ID: 17676786
[TBL] [Abstract][Full Text] [Related]
32. Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP.
Kim S; Cho SH; Kim KY; Shin KY; Kim HS; Park CH; Chang KA; Lee SH; Cho D; Suh YH
J Neurochem; 2009 Jun; 109(5):1483-96. PubMed ID: 19457162
[TBL] [Abstract][Full Text] [Related]
33. Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons.
Wang S; Chu CH; Guo M; Jiang L; Nie H; Zhang W; Wilson B; Yang L; Stewart T; Hong JS; Zhang J
J Neuroinflammation; 2016 Jun; 13(1):158. PubMed ID: 27329107
[TBL] [Abstract][Full Text] [Related]
34. Nitrated alpha-synuclein and microglial neuroregulatory activities.
Reynolds AD; Kadiu I; Garg SK; Glanzer JG; Nordgren T; Ciborowski P; Banerjee R; Gendelman HE
J Neuroimmune Pharmacol; 2008 Jun; 3(2):59-74. PubMed ID: 18202920
[TBL] [Abstract][Full Text] [Related]
35. Microglia in Parkinson's Disease.
Ho MS
Adv Exp Med Biol; 2019; 1175():335-353. PubMed ID: 31583594
[TBL] [Abstract][Full Text] [Related]
36. Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant.
Hoenen C; Gustin A; Birck C; Kirchmeyer M; Beaume N; Felten P; Grandbarbe L; Heuschling P; Heurtaux T
PLoS One; 2016; 11(9):e0162717. PubMed ID: 27622765
[TBL] [Abstract][Full Text] [Related]
37. DJ-1 deficiency impairs autophagy and reduces alpha-synuclein phagocytosis by microglia.
Nash Y; Schmukler E; Trudler D; Pinkas-Kramarski R; Frenkel D
J Neurochem; 2017 Dec; 143(5):584-594. PubMed ID: 28921554
[TBL] [Abstract][Full Text] [Related]
38. Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein.
Zhang W; Dallas S; Zhang D; Guo JP; Pang H; Wilson B; Miller DS; Chen B; Zhang W; McGeer PL; Hong JS; Zhang J
Glia; 2007 Aug; 55(11):1178-88. PubMed ID: 17600340
[TBL] [Abstract][Full Text] [Related]
39. Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson's disease.
Thomas MP; Chartrand K; Reynolds A; Vitvitsky V; Banerjee R; Gendelman HE
J Neurochem; 2007 Jan; 100(2):503-19. PubMed ID: 17241161
[TBL] [Abstract][Full Text] [Related]
40. Alpha-synuclein overexpression increases phospho-protein phosphatase 2A levels via formation of calmodulin/Src complex.
Yang W; Wang X; Duan C; Lu L; Yang H
Neurochem Int; 2013 Sep; 63(3):180-94. PubMed ID: 23796501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
